help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0531
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burniat, A.
Right arrow Articles by Corvilain, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burniat, A.
Right arrow Articles by Corvilain, B.
Endocrinology Vol. 149, No. 10 5107-5117
Copyright © 2008 by The Endocrine Society

Gene Expression in RET/PTC3 and E7 Transgenic Mouse Thyroids: RET/PTC3 But Not E7 Tumors Are Partial and Transient Models of Human Papillary Thyroid Cancers

Agnès Burniat, Ling Jin, Vincent Detours, Natacha Driessens, Jean-Christophe Goffard, Massimo Santoro, Jay Rothstein, Jacques E. Dumont, Françoise Miot and Bernard Corvilain

Institute of Interdisciplinary Research (A.B., L.J., V.D., N.D., J.-C.G., J.E.D., F.M., B.C.), School of Medicine, and Department of Endocrinology (B.C.), Erasme University Hospital, Université Libre de Bruxelles, Campus Erasme, B-1070 Brussels, Belgium; Dipartimento di Biologia e Patologia Cellulare e Molecolare (M.S.), Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, G. Salvatore, Università Federico II, 80131 Naples, Italy; Kimmel Center Institute (J.R.), Thomas Jefferson University, Philadelphia, Pennsylvania 19107; and Inflammation Research (J.R.), Amgen, Inc., Seattle, Washington 98119

Address all correspondence and requests for reprints to: Agnès Burniat, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Campus Erasme, Bat. C, Room C.4.145, Route de Lennik 808, 1070 Brussels, Belgium. E-mail: aburniat{at}ulb.ac.be.

We studied gene expression profiles in two mouse models of human thyroid carcinoma: the Tg-RET/PTC3 (RP3) and Tg-E7 mice. RP3 fusion gene is the most frequent mutation found in the first wave post-Chernobyl papillary thyroid cancers (PTCs). E7 is an oncoprotein derived from the human papillomavirus 16 responsible for most cervical carcinoma in women. Both transgenic mice develop thyroid hyperplasia followed by solid differentiated carcinoma in older animals. To understand the different steps leading to carcinoma, we analyzed thyroid gene expression in both strains at different ages by microarray technology. Important biological processes were differentially regulated in the two tumor types. In E7 thyroids, cell cycle was the most up-regulated process, an observation consistent with the huge size of these tumors. In RP3 thyroids, contrary to E7 tumors, several human PTC characteristics were observed: overexpression of many immune-related genes, regulation of human PTC markers, up-regulation of EGF-like growth factors and significant regulation of angiogenesis and extracellular matrix remodeling-related genes. However, similarities were incomplete; they did not concern the overall gene expression and were not conserved in old animals. Therefore, RP3 tumors are partial and transient models of human PTC. They constitute a good model, especially in young animals, to study the respective role of the biological processes shared with human PTC and will allow testing drugs targeting these validated variables.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
G. Prost, F. Bernier-Valentin, M. Croset, and B. Rousset
Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland
Endocr. Relat. Cancer, September 1, 2009; 16(3): 873 - 884.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society